{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:20:25Z","timestamp":1694636425557},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T00:00:00Z","timestamp":1247270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00115-009-2795-0","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T10:23:02Z","timestamp":1247134982000},"page":"1216-1218","source":"Crossref","is-referenced-by-count":0,"title":["Zerebell\u00e4res Syndrom bei Morbus Gaucher","Cerebellar syndrome in Gaucher\u2018s disease"],"prefix":"10.1007","volume":"80","author":[{"given":"B.","family":"Ukley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bachhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,11]]},"reference":[{"key":"2795_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","volume":"138","author":"Altesrescu","year":"2001","unstructured":"Altesrescu G, Hill S, Wiggs E (2001) The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher\u2019s disease. J Pediatr 138:539\u2013547","journal-title":"J Pediatr"},{"key":"2795_CR2","unstructured":"Barranger JA, Ginn EL (1989) Glucosylceramide lipidosis: Gaucher disease. In: The metabolic basis of inherited disease. 6th edn. Mc Graw-Hill, New York, pp 1677\u20131698"},{"key":"2795_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","volume":"18","author":"Brady","year":"1965","unstructured":"Brady RO, Kanfer J, Shapiro D (1965) Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease. Biochem Biophys Res Commun 18:221\u2013225","journal-title":"Biochem Biophys Res Commun"},{"key":"2795_CR4","unstructured":"Brady RO, Schiffmann R (2007) Lysosomal disorders: Gaucher disease. In: Rosenberg RN, DiMauro S, Paulson HL (eds) The molecular and genetic basis of neurologic and psychiatric disease. 4th edn. pp 209\u2013214"},{"key":"2795_CR5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5858\/2008-132-851-GDROTL","volume":"132","author":"Chen","year":"2008","unstructured":"Chen M, Wang J (2008) Gaucher disease: Review of literature. Arch Pathol Lab Med 132(5):851\u2013853","journal-title":"Arch Pathol Lab Med"},{"key":"2795_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2008-1075875","volume":"37","author":"Niederau","year":"2008","unstructured":"Niederau C (2008) Morbus Gaucher \u2013 Seltene Erkrankung mit vielen Gesichtern. Klinikarzt 37(3):2\u20136","journal-title":"Klinikarzt"},{"key":"2795_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/PL00002150","volume":"96","author":"Niederau","year":"2001","unstructured":"Niederau C, Rolfs A, vom Dahl S (2001) Diagnosis and therapy of Gaucher disease. Current recommendations of German therapy centers in the year 2000. Med Klin 96(1):32\u201339","journal-title":"Med Klin"},{"key":"2795_CR8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","volume":"39","author":"Nilsson","year":"1982","unstructured":"Nilsson O, Svennerholm L (1982) Accumulation of glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem 39(3):709\u2013718","journal-title":"J Neurochem"},{"key":"2795_CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","volume":"76","author":"Orvisky","year":"2002","unstructured":"Orvisky E, Park JK, LaMarca ME (2002) Glucosylsphingosine accumulation in tissue from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab 76(4):262\u2013270","journal-title":"Mol Genet Metab"},{"key":"2795_CR10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","volume":"14","author":"Schueler","year":"2003","unstructured":"Schueler U, Kolter T, Kaneski CR (2003) Toxicity of glucosylsphingosine (glucopsychosine) to culture neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. Neurobiol Dis 14(3):595\u2013601","journal-title":"Neurobiol Dis"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-009-2795-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-009-2795-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T08:59:22Z","timestamp":1633683562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-009-2795-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,11]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["2795"],"URL":"https:\/\/doi.org\/10.1007\/s00115-009-2795-0","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,11]]}}}